Stock Track | Vir Biotechnology (VIR) Soars 5.03% on Bullish Analyst Ratings

Stock Track

20 hours ago

Shares of Vir Biotechnology, Inc. (VIR) are surging in intraday trading, with the stock price soaring 5.03%. This significant uptick comes on the heels of bullish analyst ratings from two major financial institutions.

Morgan Stanley has reiterated its Buy rating on Vir Biotechnology, setting a price target of $20.00. This optimistic outlook suggests substantial upside potential for the stock. Additionally, TD Cowen has maintained its Buy rating on VIR, further bolstering investor confidence in the biotechnology company.

These positive assessments from respected Wall Street analysts appear to be driving the stock's impressive performance today. Investors are likely interpreting these Buy ratings as indicators of Vir Biotechnology's strong market position and growth prospects in the competitive biotech sector.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1190163920"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1190163920\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1190163920?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-12 03:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190163920","market":"sg","top_or_hot":-1,"title":"Stock Track | Vir Biotechnology (VIR) Soars 5.03% on Bullish Analyst Ratings","media":"Stock Track","content":"<p>Shares of Vir Biotechnology, Inc. (VIR) are surging in intraday trading, with the stock price soaring 5.03%. This significant uptick comes on the heels of bullish analyst ratings from two major financial institutions.</p>\n\n<p>Morgan Stanley has reiterated its Buy rating on Vir Biotechnology, setting a price target of $20.00. This optimistic outlook suggests substantial upside potential for the stock. Additionally, TD Cowen has maintained its Buy rating on VIR, further bolstering investor confidence in the biotechnology company.</p>\n\n<p>These positive assessments from respected Wall Street analysts appear to be driving the stock's impressive performance today. Investors are likely interpreting these Buy ratings as indicators of Vir Biotechnology's strong market position and growth prospects in the competitive biotech sector.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Vir Biotechnology (VIR) Soars 5.03% on Bullish Analyst Ratings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Vir Biotechnology (VIR) Soars 5.03% on Bullish Analyst Ratings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-12 03:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Vir Biotechnology, Inc. (VIR) are surging in intraday trading, with the stock price soaring 5.03%. This significant uptick comes on the heels of bullish analyst ratings from two major financial institutions.</p>\n\n<p>Morgan Stanley has reiterated its Buy rating on Vir Biotechnology, setting a price target of $20.00. This optimistic outlook suggests substantial upside potential for the stock. Additionally, TD Cowen has maintained its Buy rating on VIR, further bolstering investor confidence in the biotechnology company.</p>\n\n<p>These positive assessments from respected Wall Street analysts appear to be driving the stock's impressive performance today. Investors are likely interpreting these Buy ratings as indicators of Vir Biotechnology's strong market position and growth prospects in the competitive biotech sector.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VIR","symbol_name":"Vir Biotechnology, Inc.","start_time":0,"source_url":"","article_id":"1190163920","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190163920","pubTimestamp":1762888830,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Vir Biotechnology, Inc. (VIR) are surging in intraday trading, with the stock price soaring 5.03%. This significant uptick comes on the heels of bullish analyst ratings from two major...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VIR":"Vir Biotechnology, Inc."},"translate_title":"股票追踪|Vir Biotechnology(VIR)因分析师看涨评级飙升5.03%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VIR":1},"content_text":"Shares of Vir Biotechnology, Inc. (VIR) are surging in intraday trading, with the stock price soaring 5.03%. This significant uptick comes on the heels of bullish analyst ratings from two major financial institutions.\nMorgan Stanley has reiterated its Buy rating on Vir Biotechnology, setting a price target of $20.00. This optimistic outlook suggests substantial upside potential for the stock. Additionally, TD Cowen has maintained its Buy rating on VIR, further bolstering investor confidence in the biotechnology company.\nThese positive assessments from respected Wall Street analysts appear to be driving the stock's impressive performance today. Investors are likely interpreting these Buy ratings as indicators of Vir Biotechnology's strong market position and growth prospects in the competitive biotech sector.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}